Hypoxia, HIF1 and glucose metabolism in the solid tumour
The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Abstract
It has been known for many years that cellular metabolism within the solid tumour is markedly different from that of the corresponding normal tissue. The transcription factor hypoxia-inducible factor 1 (HIF1) has been implicated in regulating many of the genes that are responsible for the metabolic difference. However, it remains unclear how this 'aerobic glycolysis', originally described by Otto Warburg, offers tumour cells a growth advantage. As discussed in this Perspective, new data suggests that this metabolic switch may provide a benefit to the tumour not by increasing glycolysis but by decreasing mitochondrial activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Activated HIF-1 plays a crucial role in adaptive responses of the tumor cells to changes in oxygen through transcriptional activation of over 100 downstream genes which regulate vital biological processes required for tumor survival and progression.”
From HIF-1α pathway: role, regulation and intervention for cancer therapy (2015) · cites this paper as [3]
In the citing paper
“HIF-1 mediates this metabolic conversion through the induction of enzymes involved in the glycolysis pathway and overexpression of glucose transporters (GLUTs) which increase glucose import into tumor cells3.”
From HIF-1α pathway: role, regulation and intervention for cancer therapy (2015) · cites this paper as [3]
In the citing paper
“HIF-1α is activated due to blockade of its degradation pathway mediated by low oxygen levels, thereby increasing the expression of target genes, including those encoding glycolytic enzymes and glucose transporters, and increasing lactate secretion67.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [67]
Citations
Cites
Free Radicals in the Physiological Control of Cell Function
Dröge, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00018.2001 · Cited by 9,855
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
On Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Hockel, M., & Vaupel, P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.266 · Cited by 2,662 · cited 1×
“Tumour cells respond to these conditions, and adapt their metabolism to adjust the O 2 demand to meet the limited suppl”
Background
Cited by
Items 101–200 of 1,002
Collagen prolyl 4-hydroxylase 1 is essential for HIF-1α stabilization and TNBC chemoresistance
Xiong, G., Stewart, R. L., Chen, J., Gao, T., Scott, T. L., Samayoa, L. M., O’Connor, K., Lane, A. N., & Xu, R. (2018) · Nature Communications · doi:10.1038/s41467-018-06893-9 · Cited by 274
Reactive oxygen species-dependent signaling regulates cancer
Weinberg, F., & Chandel, N. S. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0099-y · Cited by 275
Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors
Xia, Y., Choi, H.-K., & Lee, K. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.01.033 · Cited by 278
Mitochondria in cancer: Not just innocent bystanders
Frezza, C., & Gottlieb, E. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.11.008 · Cited by 268
The Mitochondrial Chaperone TRAP1 Promotes Neoplastic Growth by Inhibiting Succinate Dehydrogenase
Sciacovelli, M., Guzzo, G., Morello, V., Frezza, C., Zheng, L., Nannini, N., Calabrese, F., Laudiero, G., Esposito, F., Landriscina, M., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.019 · Cited by 264
Zhang, L., Jaswal, J. S., Ussher, J. R., Sankaralingam, S., Wagg, C., Zaugg, M., & Lopaschuk, G. D. (2013) · Circulation: Heart Failure · doi:10.1161/circheartfailure.112.000228 · Cited by 269
Codon-specific translation reprogramming promotes resistance to targeted therapy
Rapino, F., Delaunay, S., Rambow, F., Zhou, Z., Tharun, L., De Tullio, P., Sin, O., Shostak, K., Schmitz, S., Piepers, J., et al. (2018) · Nature · doi:10.1038/s41586-018-0243-7 · Cited by 271
O-GlcNAcylation of G6PD promotes the pentose phosphate pathway and tumor growth
Rao, X., Duan, X., Mao, W., Li, X., Li, Z., Li, Q., Zheng, Z., Xu, H., Chen, M., Wang, P. G., et al. (2015) · Nature Communications · doi:10.1038/ncomms9468 · Cited by 257
Broekgaarden, M., Weijer, R., van Gulik, T. M., Hamblin, M. R., & Heger, M. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-015-9588-7 · Cited by 255
Emerging roles of aerobic glycolysis in breast cancer
Wu, Z., Wu, J., Zhao, Q., Fu, S., & Jin, J. (2020) · Clinical and Translational Oncology · doi:10.1007/s12094-019-02187-8 · Cited by 255
Nanozyme-involved biomimetic cascade catalysis for biomedical applications
Cai, X., Jiao, L., Yan, H., Wu, Y., Gu, W., Du, D., Lin, Y., & Zhu, C. (2021) · Materials Today · doi:10.1016/j.mattod.2020.12.005 · Cited by 260
Biomaterials tools to modulate the tumour microenvironment in immunotherapy
Chao, Y., & Liu, Z. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-022-00004-6 · Cited by 245
Choo, A. Y., Kim, S. G., Vander Heiden, M. G., Mahoney, S. J., Vu, H., Yoon, S.-O., Cantley, L. C., & Blenis, J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.007 · Cited by 253
Tricarboxylic Acid (TCA) Cycle Intermediates: Regulators of Immune Responses
Choi, I., Son, H., & Baek, J.-H. (2021) · Life · doi:10.3390/life11010069 · Cited by 241
Guo, W., Qiu, Z., Wang, Z., Wang, Q., Tan, N., Chen, T., Chen, Z., Huang, S., Gu, J., Li, J., et al. (2015) · Hepatology · doi:10.1002/hep.27929 · Cited by 250
Tumor cell metabolism: An integral view
Romero-Garcia, S., Lopez-Gonzalez, J. S., B´ez-Viveros, J. L., Aguilar-Cazares, D., & Prado-Garcia, H. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.12.11.18140 · Cited by 235
Bioprinting the Cancer Microenvironment
Zhang, Y. S., Duchamp, M., Oklu, R., Ellisen, L. W., Langer, R., & Khademhosseini, A. (2016) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00246 · Cited by 248
Sutendra, G., Bonnet, S., Rochefort, G., Haromy, A., Folmes, K. D., Lopaschuk, G. D., Dyck, J. R. B., & Michelakis, E. D. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001327 · Cited by 245
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis
Aldiri, I., Xu, B., Wang, L., Chen, X., Hiler, D., Griffiths, L., Valentine, M., Shirinifard, A., Thiagarajan, S., Sablauer, A., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.04.022 · Cited by 262
The Warburg effect: Insights from the past decade
Upadhyay, M., Samal, J., Kandpal, M., Singh, O. V., & Vivekanandan, P. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.11.003 · Cited by 243
Kaji, K., Nishimura, N., Seki, K., Sato, S., Saikawa, S., Nakanishi, K., Furukawa, M., Kawaratani, H., Kitade, M., Moriya, K., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31193 · Cited by 241
Mitochondria in Vascular Health and Disease
Dromparis, P., & Michelakis, E. D. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183804 · Cited by 236
Peck, B., Schug, Z. T., Zhang, Q., Dankworth, B., Jones, D. T., Smethurst, E., Patel, R., Mason, S., Jiang, M., Saunders, R., et al. (2016) · Cancer & Metabolism · doi:10.1186/s40170-016-0146-8 · Cited by 254
Wang, H., Xue, K.-F., Yang, Y., Hu, H., Xu, J.-F., & Zhang, X. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.1c13067 · Cited by 243
Meiser, J., Krämer, L., Sapcariu, S. C., Battello, N., Ghelfi, J., D'Herouel, A. F., Skupin, A., & Hiller, K. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.676817 · Cited by 243
“A well described HIF1 target is the gene encoding pyruvate dehydrogenase kinase 1 (PDK1), an inhibitor of Pyruvate dehydrogenase (PDH)(3) (11).”
BackgroundThe Glycolytic Switch in Tumors: How Many Players Are Involved?
Yu, L., Chen, X., Sun, X., Wang, L., & Chen, S. (2017) · Journal of Cancer · doi:10.7150/jca.21125 · Cited by 233
Regulation of Tumor Progression by Programmed Necrosis
Lee, S. Y., Ju, M. K., Jeon, H. M., Jeong, E. K., Lee, Y. J., Kim, C. H., Park, H. G., Han, S. I., & Kang, H. S. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/3537471 · Cited by 215
Ruthenium-Based Photoactivated Chemotherapy
Bonnet, S. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c01135 · Cited by 228
Waves of gene regulation suppress and then restore oxidative phosphorylation in cancer cells
Smolková, K., Plecitá-Hlavatá, L., Bellance, N., Benard, G., Rossignol, R., & Ježek, P. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.05.003 · Cited by 223
Ryoo, I.-G., & Kwak, M.-K. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.09.014 · Cited by 220
Nonalcoholic fatty liver disease in adults: current concepts in etiology, outcomes, and management
Marjot, T., Moolla, A., Cobbold, J. F., Hodson, L., & Tomlinson, J. W. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnz009 · Cited by 228
Adenanthin targets peroxiredoxin I and II to induce differentiation of leukemic cells
Liu, C.-X., Yin, Q.-Q., Zhou, H.-C., Wu, Y.-L., Pu, J.-X., Xia, L., Liu, W., Huang, X., Jiang, T., Wu, M.-X., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.935 · Cited by 221
Cardamonin inhibits breast cancer growth by repressing HIF-1α-dependent metabolic reprogramming
Jin, J., Qiu, S., Wang, P., Liang, X., Huang, F., Wu, H., Zhang, B., Zhang, W., Tian, X., Xu, R., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1351-4 · Cited by 225
Zachar, Z., Marecek, J., Maturo, C., Gupta, S., Stuart, S. D., Howell, K., Schauble, A., Lem, J., Piramzadian, A., Karnik, S., et al. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0785-8 · Cited by 216
Glucose Oxidation Modulates Anoikis and Tumor Metastasis
Kamarajugadda, S., Stemboroski, L., Cai, Q., Simpson, N. E., Nayak, S., Tan, M., & Lu, J. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06248-11 · Cited by 216
Arginine Starvation Impairs Mitochondrial Respiratory Function in ASS1-Deficient Breast Cancer Cells
Qiu, F., Chen, Y.-R., Liu, X., Chu, C.-Y., Shen, L.-J., Xu, J., Gaur, S., Forman, H. J., Zhang, H., Zheng, S., et al. (2014) · Science Signaling · doi:10.1126/scisignal.2004761 · Cited by 217
MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines
Grosso, S., Doyen, J., Parks, S. K., Bertero, T., Paye, A., Cardinaud, B., Gounon, P., Lacas-Gervais, S., Noël, A., Pouysségur, J., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.71 · Cited by 216
An, J., Hu, Y.-G., Cheng, K., Li, C., Hou, X.-L., Wang, G.-L., Zhang, X.-S., Liu, B., Zhao, Y.-D., & Zhang, M.-Z. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119761 · Cited by 217
Sudarshan, S., Sourbier, C., Kong, H.-S., Block, K., Romero, V. A. V., Yang, Y., Galindo, C., Mollapour, M., Scroggins, B., Goode, N., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00483-09 · Cited by 217
“Previous reports have suggested that failure to do so may slow glycolysis by-product feedback inhibition (4).”
BackgroundGanapathy-Kanniappan, S. (2018) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2018.1556578 · Cited by 216
Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer
Varghese, E., Samuel, S. M., Líšková, A., Samec, M., Kubatka, P., & Büsselberg, D. (2020) · Cancers · doi:10.3390/cancers12082252 · Cited by 208
p38α MAPK pathway: A key factor in colorectal cancer therapy and chemoresistance
Grossi, V. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i29.9744 · Cited by 214
Metabolic Reprogramming by the PI3K-Akt-mTOR Pathway in Cancer
Lien, E. C., Lyssiotis, C. A., & Cantley, L. C. (2016) · Recent Results in Cancer Research · doi:10.1007/978-3-319-42118-6_3 · Cited by 212
Tumor Microenvironment‐Enabled Nanotherapy
Wang, L., Huo, M., Chen, Y., & Shi, J. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701156 · Cited by 213
Mitochondrial Akt Regulation of Hypoxic Tumor Reprogramming
Chae, Y. C., Vaira, V., Caino, M. C., Tang, H.-Y., Seo, J. H., Kossenkov, A. V., Ottobrini, L., Martelli, C., Lucignani, G., Bertolini, I., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.07.004 · Cited by 209
Metabolic Signature Identifies Novel Targets for Drug Resistance in Multiple Myeloma
Maiso, P., Huynh, D., Moschetta, M., Sacco, A., Aljawai, Y., Mishima, Y., Asara, J. M., Roccaro, A. M., Kimmelman, A. C., & Ghobrial, I. M. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3400 · Cited by 208
Gordijo, C. R., Abbasi, A. Z., Amini, M. A., Lip, H. Y., Maeda, A., Cai, P., O'Brien, P. J., DaCosta, R. S., Rauth, A. M., & Wu, X. Y. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201404511 · Cited by 209
Successively activatable ultrasensitive probe for imaging tumour acidity and hypoxia
Zheng, X., Mao, H., Huo, D., Wu, W., Liu, B., & Jiang, X. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0057 · Cited by 210
BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers
Castellani, G., Buccarelli, M., Arasi, M. B., Rossi, S., Pisanu, M. E., Bellenghi, M., Lintas, C., & Tabolacci, C. (2023) · Cancers · doi:10.3390/cancers15164026 · Cited by 186
Sutendra, G., Dromparis, P., Paulin, R., Zervopoulos, S., Haromy, A., Nagendran, J., & Michelakis, E. D. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1059-4 · Cited by 204
Hedgehog signaling: modulation of cancer properies and tumor mircroenvironment
Hanna, A., & Shevde, L. A. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0509-3 · Cited by 205
Oxygen availability and metabolic reprogramming in cancer
Xie, H., & Simon, M. C. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r117.799973 · Cited by 206
Entosis Is Induced by Glucose Starvation
Hamann, J. C., Surcel, A., Chen, R., Teragawa, C., Albeck, J. G., Robinson, D. N., & Overholtzer, M. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.037 · Cited by 203
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript during tumorigenesis (Denko, 2008), may induce entosis in human cancers.”
Redox Control of Liver Function in Health and Disease
Marí, M., Colell, A., Morales, A., von Montfort, C., Garcia-Ruiz, C., & Fernández-Checa, J. C. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2634 · Cited by 203
A Cellular Mechanism to Detect and Alleviate Reductive Stress
Manford, A. G., Rodríguez-Pérez, F., Shih, K. Y., Shi, Z., Berdan, C. A., Choe, M., Titov, D. V., Nomura, D. K., & Rape, M. (2020) · Cell · doi:10.1016/j.cell.2020.08.034 · Cited by 191
von Heideman, A., Berglund, Å., Larsson, R., & Nygren, P. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1125-3 · Cited by 201
“This phenomenon may be advantageous to the tumour cell but could also be exploited therapeutically by development of drugs inhibiting glycolysis [4].”
BackgroundLiu, Y., Ji, X., Tong, W. W. L., Askhatova, D., Yang, T., Cheng, H., Wang, Y., & Shi, J. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201710144 · Cited by 199
Metabolic reprogramming in osteoclasts
Park-Min, K.-H. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00757-0 · Cited by 191
Wnt/Snail Signaling Regulates Cytochrome c Oxidase and Glucose Metabolism
Lee, S. Y., Jeon, H. M., Ju, M. K., Kim, C. H., Yoon, G., Han, S. I., Park, H. G., & Kang, H. S. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0006 · Cited by 195
Feedback regulation via AMPK and HIF-1 mediates ROS-dependent longevity in Caenorhabditis elegans
Hwang, A. B., Ryu, E.-A., Artan, M., Chang, H.-W., Kabir, M. H., Nam, H.-J., Lee, D., Yang, J.-S., Kim, S., Mair, W. B., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411199111 · Cited by 188
Peppicelli, S., Bianchini, F., & Calorini, L. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-014-9506-4 · Cited by 192
Oxygen Consumption Can Regulate the Growth of Tumors, a New Perspective on the Warburg Effect
Chen, Y., Cairns, R., Papandreou, I., Koong, A., & Denko, N. C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007033 · Cited by 187
Self-citationPET Monitoring of Therapy Response in Head and Neck Squamous Cell Carcinoma
Schöder, H., Fury, M., Lee, N., & Kraus, D. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057208 · Cited by 192
Targeting Metabolic Remodeling in Glioblastoma Multiforme
Wolf, A., Agnihotri, S., & Guha, A. (2010) · Oncotarget · doi:10.18632/oncotarget.190 · Cited by 188
Bcl-6 directly represses the gene program of the glycolysis pathway
Oestreich, K. J., Read, K. A., Gilbertson, S. E., Hough, K. P., McDonald, P. W., Krishnamoorthy, V., & Weinmann, A. S. (2014) · Nature Immunology · doi:10.1038/ni.2985 · Cited by 186
Metabolic adaptation of cancer and immune cells mediated by hypoxia-inducible factors
Samanta, D., & Semenza, G. L. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.07.002 · Cited by 190
Epidermal Growth Factor Receptor Translocation to the Mitochondria
Demory, M. L., Boerner, J. L., Davidson, R., Faust, W., Miyake, T., Lee, I., Hüttemann, M., Douglas, R., Haddad, G., & Parsons, S. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.000760 · Cited by 184
Disorders of cancer metabolism: The therapeutic potential of cannabinoids
Sun, D., Li, X., Nie, S., Liu, J., & Wang, S. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113993 · Cited by 182
Sutendra, G., Dromparis, P., Kinnaird, A., Stenson, T. H., Haromy, A., Parker, J. M. R., McMurtry, M. S., & Michelakis, E. D. (2013) · Oncogene · doi:10.1038/onc.2012.198 · Cited by 184
Hypoxia and Selective Autophagy in Cancer Development and Therapy
Daskalaki, I., Gkikas, I., & Tavernarakis, N. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00104 · Cited by 188
Adenine nucleotide translocase 2 is a key mitochondrial protein in cancer metabolism
Chevrollier, A., Loiseau, D., Reynier, P., & Stepien, G. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.10.008 · Cited by 181
Hypoxic Induction of Vasorin Regulates Notch1 Turnover to Maintain Glioma Stem-like Cells
Man, J., Yu, X., Huang, H., Zhou, W., Xiang, C., Huang, H., Miele, L., Liu, Z., Bebek, G., Bao, S., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2017.10.005 · Cited by 186
Hypoxia: The Cornerstone of Glioblastoma
Domènech, M., Hernández, A., Plaja, A., Martínez-Balibrea, E., & Balañà, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212608 · Cited by 173
Metabolic memory: mechanisms and diseases
Dong, H., Sun, Y., Nie, L., Cui, A., Zhao, P., Leung, W. K., & Wang, Q. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01755-x · Cited by 214
Role of the VEGF/VEGFR Axis in Cancer Biology and Therapy
(2012) · Advances in Cancer Research · doi:10.1016/b978-0-12-386503-8.00006-5 · Cited by 180
Hou, Y., Zhang, Q., Pang, W., Hou, L., Liang, Y., Han, X., Luo, X., Wang, P., Zhang, X., Li, L., et al. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-021-00804-0 · Cited by 183
Chen, H., Deng, Y., Gan, X., Li, Y., Huang, W., Lu, L., Wei, L., Su, L., Luo, J., Zou, B., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00372-w · Cited by 182
Nanoplatform-based cascade engineering for cancer therapy
Chen, J., Zhu, Y., Wu, C., & Shi, J. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00607f · Cited by 182
Bao, B., Azmi, A. S., Ali, S., Ahmad, A., Li, Y., Banerjee, S., Kong, D., & Sarkar, F. H. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.04.008 · Cited by 180
Long-term reprogramming of the innate immune system
Dominguez-Andres, J., & Netea, M. G. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.mr0318-104r · Cited by 170
Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia
Rapisarda, A., & Melillo, G. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.64 · Cited by 176
Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression
Heinecke, J. L., Ridnour, L. A., Cheng, R. Y. S., Switzer, C. H., Lizardo, M. M., Khanna, C., Glynn, S. A., Hussain, S. P., Young, H. A., Ambs, S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401799111 · Cited by 177
“Hypoxia activates various oncogenic and metabolic pathways (13) and is a hallmark of aggressive tumors (14).”
BackgroundYang, B., Chen, Y., & Shi, J. (2019) · Materials Science and Engineering: R: Reports · doi:10.1016/j.mser.2019.01.001 · Cited by 171
Metabolic rewiring in melanoma
Ratnikov, B. I., Scott, D. A., Osterman, A. L., Smith, J. W., & Ronai, Z. A. (2017) · Oncogene · doi:10.1038/onc.2016.198 · Cited by 171
Hypoxia and hypoxia inducible factors in tumor metabolism
Zeng, W., Liu, P., Pan, W., Singh, S. R., & Wei, Y. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.01.032 · Cited by 170
Altered cancer metabolism in mechanisms of immunotherapy resistance
Ramapriyan, R., Caetano, M. S., Barsoumian, H. B., Mafra, A. C. P., Zambalde, E. P., Menon, H., Tsouko, E., Welsh, J. W., & Cortez, M. A. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.004 · Cited by 170
Goodwin, J., Choi, H., Hsieh, M.-H., Neugent, M. L., Ahn, J.-M., Hayenga, H. N., Singh, P. K., Shackelford, D. B., Lee, I.-K., Shulaev, V., et al. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0186oc · Cited by 166
Overexpression of hypoxia-inducible factor and metabolic pathways: possible targets of cancer
Singh, D., Arora, R., Kaur, P., Singh, B., Mannan, R., & Arora, S. (2017) · Cell & Bioscience · doi:10.1186/s13578-017-0190-2 · Cited by 166
Zhao, L., Cui, C., Liu, Q., Sun, J., He, K., Adam, A. A., Luo, J., Li, Z., Wang, Y., & Yang, S. (2020) · Aquatic Toxicology · doi:10.1016/j.aquatox.2020.105514 · Cited by 165
The Epithelial–Mesenchymal Transition at the Crossroads between Metabolism and Tumor Progression
Fedele, M., Sgarra, R., Battista, S., Cerchia, L., & Manfioletti, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020800 · Cited by 171
Multiple functions of hypoxia-regulated miR-210 in cancer
Qin, Q., Furong, W., & Baosheng, L. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-33-50 · Cited by 165
Empowering self-renewal and differentiation: the role of mitochondria in stem cells
Rehman, J. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0678-2 · Cited by 163
Glucose Metabolism and Glucose Transporters in Breast Cancer
Shin, E., & Koo, J. S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.728759 · Cited by 164
Jia, N., Gao, Y., Li, M., Liang, Y., Li, Y., Lin, Y., Huang, S., Lin, Q., Sun, X., He, Q., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01499-0 · Cited by 158
Chromatin regulation and genome maintenance by mammalian SIRT6
Tennen, R. I., & Chua, K. F. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.07.009 · Cited by 164
Anticancer Agents That Counteract Tumor Glycolysis
Granchi, C., & Minutolo, F. (2012) · ChemMedChem · doi:10.1002/cmdc.201200176 · Cited by 166
Pereira, E. R., Liao, N., Neale, G. A. M., & Hendershot, L. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012521 · Cited by 177
Plebanek, M. P., Xue, Y., Nguyen, Y.-V., DeVito, N. C., Wang, X., Holtzhausen, A., Beasley, G. M., Theivanthiran, B., & Hanks, B. A. (2024) · Science Immunology · doi:10.1126/sciimmunol.adi4191 · Cited by 164
“Melanomas have a notably high rate of aerobic glycolysis, leading to the acidification of the TME via the production of lactic acid ( 49 , 50 ).”
BackgroundDiverse roles of ANGPTL2 in physiology and pathophysiology
Kadomatsu, T., Endo, M., Miyata, K., & Oike, Y. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2014.03.012 · Cited by 160
Shi, X., Zhou, H., Wei, J., Mo, W., Li, Q., & Lv, X. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102553 · Cited by 178
Metadata
- Authors
- Denko, N. C.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Denko, Nicholas C.
- ORCID
- Denko, Nicholas C.
- Venue
- Nature Reviews Cancer
- Published
- 2008-08-14
- Volume
- 8
- Issue
- 9
- Pages
- 705-713
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2066379425
- Cited by
- 1,707
- References
- 126
- Citations by year
- 2026: 48 · 2025: 60 · 2024: 93 · 2023: 113 · 2022: 141 · 2021: 149 · 2020: 115 · 2019: 120 · 2018: 126 · 2017: 94 · 2016: 115 · 2015: 78 · 2014: 95 · 2013: 79 · 2012: 77
- FWCI
- 4.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (P01CA067166)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- hypoxia, HIF-1, glucose metabolism, solid tumors, aerobic glycolysis, Warburg effect, cancer metabolism, mitochondrial activity, tumor growth
- MeSH terms
- Cell Division, Glucose, Glycolysis, Humans, Mitochondria, Models, Biological, Neoplasms, Cell Hypoxia, Gene Expression Regulation, Neoplastic, Reactive Oxygen Species, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.